Wendy S. Johnson Reneo Pharmaceuticals, Inc. (RPHM) insider trading activity

RPHM Quotes by TradingView

Wendy S. Johnson is Chief Development Officer of Reneo Pharmaceuticals, Inc.. Currently has a direct ownership of 0 shares of RPHM, which is worth approximately $0. The most recent transaction as insider was on Jul 14, 2021, when has been sold 111,736 shares (Common Stock) at a price of $8.5 per share, resulting in proceeds of $949,756. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 0
0% 3M change
0% 12M change
Total Value Held $0

Wendy S. Johnson Transaction History

Date Transaction Value Shares Traded Shares Held Form
Jul 14 2021
SELL
Open market or private sale
$949,756 $8.5 p/Share
111,736 Reduced 100.0%
0 Common Stock
Jul 08 2021
BUY
Exercise of conversion of derivative security
$220,120 $1.97 p/Share
111,736 Added 50.0%
111,736 Common Stock

Also insider at

XGN
EXAGEN INC. Healthcare
Director
WSJ

Wendy S. Johnson

Chief Development Officer
Vista, CA

Track Institutional and Insider Activities on RPHM

Follow Reneo Pharmaceuticals, Inc. and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells RPHM shares.

Notify only if

Insider Trading

Get notified when an Reneo Pharmaceuticals, Inc. insider buys or sells RPHM shares.

Notify only if

News

Receive news related to Reneo Pharmaceuticals, Inc.

Choose your preferred platform and Sign Up 👇 Telegram Email
Track Activities on RPHM